Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso.
Seasonal malaria chemoprevention (SMC), with regular use of amodiaquine plus sulfadoxine-pyrimethamine (AQ/SP) during the transmission season, is now a standard malaria control measure in the Sahel subregion of Africa. Another strategy under study is SMC with dihydroartemisinin plus piperaquine (DP)...
Main Authors: | Somé, A, Zongo, I, Compaoré, Y, Sakandé, S, Nosten, F, Ouédraogo, J, Rosenthal, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Microbiology
2014
|
Similar Items
-
Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso
by: Zongo, I, et al.
Published: (2015) -
Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria
by: Lucy C Okell, et al.
Published: (2022-05-01) -
Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
by: Somé Anyirékun Fabrice, et al.
Published: (2016-01-01) -
Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
by: Anyirékun Fabrice Somé, et al.
Published: (2022-08-01) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Chotsiri, P, et al.
Published: (2019)